Physician
O'connell, Emily
O'connell, Emily was paid $390K by Medicaid between Jan 2020 and Mar 2023, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoO'CONNELL, EMILY
FALMOUTH, MA 02540
FALMOUTH, MA 02540
33aNPI1821315250assigned 04/25/2010
33bProvider typePediatrics Physician
28Total paid$390K
24GClaims8,915
24DCodes billed20
24AFirst – last monthJan 2020 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#181 of 1,273
Median peer was paid$24K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,034 | $73K | |
| 2021 | 2,962 | $133K | |
| 2022 | 3,236 | $152K | |
| 2023 | 683 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 1,010 | 965 | $106K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 1,438 | 1,360 | $84K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14% | 1,095 | 1,064 | $56K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.4% | 509 | 500 | $37K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.8% | 776 | 776 | $31K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.3% | 1,242 | 1,239 | $13K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.2% | 152 | 152 | $13K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.9% | 1,248 | 1,248 | $11K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.8% | 449 | 439 | $11K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 79 | 79 | $7K |
| 87634 | 1.7% | 215 | 209 | $6K | |
| 90461 | 1.2% | 123 | 123 | $5K |
8 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 27 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 24 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 104 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 47 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 20 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 49 | $598.29 |
| 94760 | <1% | 271 | $534.60 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 37 | $452.51 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.